Skip to main content

Advertisement

Log in

Primary Immunodeficiency Diseases in Children: 15 Year Experience in a Tertiary Care Medical Center in Qatar

  • Original Research
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

Background

Primary immunodeficiency diseases (PID) are a group of heterogeneous, rare, genetic, mainly childhood disorders that affect specific components of immune system leading to serious complications.

Objectives

This study is aimed at describing the prevalence and the categories of PID, the ages of onset and the diagnosis, the clinical presentations, the treatment modalities and the overall outcome of affected patients.

Materials and Methods

A retrospective study was conducted on 131 pediatric patients (aged 0–14 years) diagnosed with PID at Hamad General Hospital during a 15-year period (1998–2012).

Results

Data of 131 patients (75 males & 56 females) was analyzed with an estimated prevalence of 4.7 PID patients per 100,000 children younger than 14 years of age. The most common type of PID was predominantly antibody deficiency (23.7 %), followed by other well-defined immunodeficiency syndromes (22.9 %), 19.1 % combined T and B cell immunodeficiency, but rare CVID, and no cases of complement deficiency. The mean onset age was 24.01 months and diagnosis age was 42.2 months. Recurrent infections, particularly pneumonia (48.9 %), failure to thrive (34.4 %), otitis media (26 %), sepsis (23.7 %), and chronic diarrhoea (21.4 %) were commonest presenting conditions. P. aeruginosa (15.7 %), Salmonella species (13.2 %), and Non-TB mycobacteria (13.2 %) were the most common bacterial isolates. The overall mortality rate was 21.4 % with combined immunodeficiency’s accounting for 53.4 % of deaths.

Conclusions

This study reveals that PIDs are not rare in children in Qatar; and like other studies predominantly antibody deficiencies are the most common. Strategies that reinforce awareness and education of practicing physicians, bone marrow transplantation, and establishing PID national registry should be adopted to reduce mortality and morbidity of PID patients in Qatar.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Rezaei N, Bonilla FA, Sullivan KE, et al. Chapter 1. An introduction to primary immunodeficiency diseases. In: Nima R, Asghar A, Notarangelo LD, editors. Primary immunodeficiency diseases, definition diagnosis and management. Berlin: Springer; 2008. p. 1–38.

    Chapter  Google Scholar 

  2. Rezaei N, Hedayat M, Aghamohammadi A, Nichols KE. Primary immunodeficiency diseases associated with increased susceptibility to viral infections and malignancies. J Allergy Clin Immunol. 2011;127:1329–41.e2; quiz 1342–3.

    Google Scholar 

  3. Leechawengwongs E, Shearer WT. Lymphoma complicating primary immunodeficiency syndromes. Curr Opin Hematol. 2012;19:305–12.

    Article  PubMed  CAS  Google Scholar 

  4. Goyal R, Bulua A, Nikolov N, et al. Rheumatologic and autoimmune manifestations of primary immunodeficiency disorders. Curr Opin Rheumatol. 2009;21:78–84.

    Article  PubMed  Google Scholar 

  5. Joshi AY VV, Hagan JB, St Sauver JL, Boyce TG. Incidence and temporal trends of primary immunodeficiency: a population-based cohort study. Mayo Clin Proc. 2009;84:16–22.

    Article  PubMed  Google Scholar 

  6. Nourijelyani K, Aghamohammadi A, Sadaghiani MS, et al. Physicians awareness on primary immunodeficiency disorders in Iran. Iran J Allergy Asthma Immunol. 2012;11:57–64.

    PubMed  Google Scholar 

  7. de Vries E, European Society for Immunodeficiencies (ESID) members. Patient-centred screening for primary immunodeficiency, a multi-stage diagnostic protocol designed for non-immunologists: 2011 update. Clin Exp Immunol. 2012;167:108–19.

    Article  PubMed  Google Scholar 

  8. Modell V, Gee B, Lewis DB et al. Global study of primary immunodeficiency diseases (PI)-diagnosis, treatment, and economic impact: an updated report from the Jeffrey Modell Foundation. Immunol Res 2011; 61–70.

  9. Yüksek M, Ikincioğullari A, Doğu F, et al. Primary immune deficiency disease awareness among a group of Turkish physicians. Turk J Pediatr. 2010;52:372–7.

    PubMed  Google Scholar 

  10. Reda SM, Afifi HM, Amine MM. Primary immunodeficiency diseases in Egyptian children: a single-center study. J Clin Immunol. 2008;29:343–51.

    Article  PubMed  Google Scholar 

  11. Barbouche MR, Galal N, Ben-Mustapha I, et al. Primary immunodeficiencies in highly consanguineous North African populations. Ann N Y Acad Sci. 2011;1238:42–52.

    Article  PubMed  Google Scholar 

  12. Aghamohammadi A, Moin M, Rezaei N. History of primary immunodeficiency diseases in Iran. Iran J Pediatr. 2010;20:16–34.

    PubMed  Google Scholar 

  13. Rezaei N, Aghamohammadi A, Moin M, et al. Frequency and clinical manifestations of patients with primary immunodeficiency disorders in Iran: update from the Iranian Primary Immunodeficiency Registry. J Clin Immunol. 2006;26:519–32.

    Article  PubMed  Google Scholar 

  14. Dar-Odeh NS, Hayajneh WA, Abu-Hammad OA, et al. Orofacial findings in chronic granulomatous disease: report of twelve patients and review of the literature. BMC Res Notes. 2010;17:37.

    Article  Google Scholar 

  15. Al-Herz W. Primary immunodeficiency disorders in Kuwait: first report from Kuwait National Primary Immunodeficiency Registry (2004–2006). J Clin Immunol. 2008;28:186–93.

    Article  PubMed  Google Scholar 

  16. Al-Herz W, Zainal M, Salama M, et al. Primary immunodeficiency disorders: survey of pediatricians in Kuwait. J Clin Immunol. 2008;28:379–83.

    Article  PubMed  Google Scholar 

  17. Al-Herz W, Bousfiha A, Casanova JL, et al. Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front Immunol. 2011;2:54. Epub 2011 Nov 2018.

    PubMed  Google Scholar 

  18. http://www.esid.org/clinical-diagnostic-criteria-for-pid-73-0.

  19. Ehlayel M, de Beaucoudrey L, Fike F, et al. Simultaneous presentation of 2 rare hereditary immunodeficiencies: IL-12 receptor beta1 deficiency and ataxia-telangiectasia. J Allergy Clin Immunol. 2008;122:1217–9.

    Article  PubMed  Google Scholar 

  20. Meller J, Malinin NL, Panigrahi S, et al. Novel aspects of Kindlin-3 function in humans based on a new case of leukocyte adhesion deficiency III (LAD-III). J Thromb Haemost. 2012;10:1397–408.

    Article  PubMed  CAS  Google Scholar 

  21. Statistical Authority of Qatar. www.qsa.gov.qa [Last visited July 5th, 2012].

  22. Qatar Financial Centre Authority. www.qfc.com.qa [Last visited July 5th, 2012].

  23. Naidoo R, Ungerer L, Cooper M, et al. Primary immunodeficiencies: a 27-year review at a tertiary paediatric hospital in Cape Town, South Africa. J Clin Immunol. 2011;31:99–105.

    Article  PubMed  Google Scholar 

  24. Gupta S, Madkaikar M, Singh S, Sehgal S. Primary immunodeficiencies in India: a perspective. Ann N Y Acad Sci. 2012;1250:73–9.

    Article  PubMed  CAS  Google Scholar 

  25. http://www.esid.org/esid_registry.php.

  26. Leiva LE, Zelazco M, Oleastro M, et al. Primary immunodeficiency diseases in Latin America: the second report of the LAGID registry. J Clin Immunol. 2007;27:101–8.

    Article  PubMed  Google Scholar 

  27. Golan H, Dalal I, Garty BZ, et. al. The incidence of primary immunodeficiency syndromes in Israel. Isr Med Assoc J 2002; 868–871.

  28. Sanal O, Tezcan I. Thirty years of primary immunodeficiencies in Turkey. Ann N Y Acad Sci. 2011;1238:15–23.

    Article  PubMed  Google Scholar 

  29. Al-Tamemi S, Ibtisam E, Dennison D. Primary immunodeficiency diseases in Oman: five years’ experience at Sultan Qaboos University Hospital. World Allergy Organ J. 2012;5:52–6.

    Article  PubMed  Google Scholar 

  30. Al-Muhsen S, Casanova JL. The genetic heterogeneity of mendelian susceptibility to mycobacterial diseases. J Allergy Clin Immunol. 2008;122:1043–51.

    Article  PubMed  CAS  Google Scholar 

  31. Fieschi C, Dupuis S, Catherinot E, et al. Low penetrance, broad resistance, and favorable outcome of interleukin 12 receptor beta1 deficiency: medical and immunological implications. J Exp Med. 2003;197:527–35.

    Article  PubMed  CAS  Google Scholar 

  32. Lee WI, Kuo ML, Huang JL, et al. Distribution and clinical aspects of primary immunodeficiencies in a Taiwan pediatric tertiary hospital during a 20-year period. J Clin Immunol. 2005;25:162–73.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors would like to thank Hamad Medical Corporation for their support and ethical approval (HMC Research Protocol No. 10078/10)

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mohammad S. Ehlayel.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ehlayel, M.S., Bener, A. & Laban, M.A. Primary Immunodeficiency Diseases in Children: 15 Year Experience in a Tertiary Care Medical Center in Qatar. J Clin Immunol 33, 317–324 (2013). https://doi.org/10.1007/s10875-012-9812-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10875-012-9812-y

Keywords

Navigation